Skip to main content
Erschienen in: Journal of Nuclear Cardiology 2/2020

25.04.2018 | Original Article

Relationship between microvascular changes, autonomic denervation, and myocardial fibrosis in Chagas cardiomyopathy: Evaluation by MRI and SPECT imaging

verfasst von: Gustavo Canavaci Barizon, MSc, Marcus Vinicius Simões, MD, PhD, André Schmidt, MD, PhD, Leonardo Pippa Gadioli, MD, PhD, Luiz Otávio Murta Junior, PhD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Background

The relationship between microvasculopathy, autonomic denervation, and myocardial fibrosis, in Chagas cardiomyopathy is incompletely understood. The aim of this study was to explore the relative extent and anatomic distribution of myocardial hypoperfusion, autonomic denervation, and myocardial scarring using Single-Photon Emission Computerized Tomography (SPECT) imaging and Magnetic Resonance Imaging (MRI).

Methods

Thirteen patients with Chagas disease all had Iodine-123-metaiodobenzylguanidine (MIBG) SPECT, 99mTc-Sestamibi (MIBI) rest-stress SPECT, and gadolinium late enhancement MRI imaging within a 2-month interval. The anatomic location and extent of denervation, of stress-induced hypoperfusion and fibrosis, were assessed through image co-registration and quantification of abnormal tissue areas as a percent of total myocardium.

Results

The results showed a strong general anatomic concordance between areas of hypoperfusion, denervation, and fibrosis, suggesting that the three abnormal features may be correlated. Myocardial denervation was anatomically and quantitatively closely associated areas of stress hypoperfusion.

Conclusion

Combined myocardial analysis of the extent and location of autonomic denervation, hypoperfusion, and scarring may allow for better understanding of the pathophysiology of Chagas cardiomyopathy. Autonomic myocardial denervation may be a more sensitive marker of cardiac involvement in Chagas Disease than finding by other imaging modalities.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Control of Chagas disease: Second report of the WHO Expert Committee. World Heal Organ 2002. p. 905 Control of Chagas disease: Second report of the WHO Expert Committee. World Heal Organ 2002. p. 905
2.
Zurück zum Zitat Rassi A, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010;375:1388-402.CrossRef Rassi A, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010;375:1388-402.CrossRef
3.
Zurück zum Zitat Muñoz-Saravia SG, Haberland A, Wallukat G, Schimke I. Chronic Chagas’ heart disease: A disease on its way to becoming a worldwide health problem: Epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine. Heart Fail Rev 2012;17:45-64.CrossRef Muñoz-Saravia SG, Haberland A, Wallukat G, Schimke I. Chronic Chagas’ heart disease: A disease on its way to becoming a worldwide health problem: Epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine. Heart Fail Rev 2012;17:45-64.CrossRef
4.
Zurück zum Zitat Marin-Neto JA, Simões MV, Rassi Junior A. Pathogenesis of chronic Chagas cardiomyopathy: The role of coronary microvascular derangements. Rev Soc Bras Med Trop 2013;46:536-41.CrossRef Marin-Neto JA, Simões MV, Rassi Junior A. Pathogenesis of chronic Chagas cardiomyopathy: The role of coronary microvascular derangements. Rev Soc Bras Med Trop 2013;46:536-41.CrossRef
5.
Zurück zum Zitat Marin-Neto JA, Cunha-Neto E, Maciel BC, Simões MV. Pathogenesis of chronic Chagas heart disease. Circulation 2007;115:1109-23.CrossRef Marin-Neto JA, Cunha-Neto E, Maciel BC, Simões MV. Pathogenesis of chronic Chagas heart disease. Circulation 2007;115:1109-23.CrossRef
6.
Zurück zum Zitat Simões MV, Pintya AO, Bromberg-Marin G, Sarabanda ÁV, Antloga CM, Pazin-Filho A, et al. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas’ cardiomyopathy. Am J Cardiol 2000;86:975-81.CrossRef Simões MV, Pintya AO, Bromberg-Marin G, Sarabanda ÁV, Antloga CM, Pazin-Filho A, et al. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas’ cardiomyopathy. Am J Cardiol 2000;86:975-81.CrossRef
7.
Zurück zum Zitat Miranda CH, Figueiredo AB, Maciel BC, Marin-Neto JA, Simões MV. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy. J Nucl Med 2011;52:504-10.CrossRef Miranda CH, Figueiredo AB, Maciel BC, Marin-Neto JA, Simões MV. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy. J Nucl Med 2011;52:504-10.CrossRef
8.
Zurück zum Zitat Higuchi MDL, Benvenuti LA, Reis MM, Metzger M. Pathophysiology of the heart in Chagas’ disease: Current status and new developments. Cardiovasc Res 2003;60:96-107.CrossRef Higuchi MDL, Benvenuti LA, Reis MM, Metzger M. Pathophysiology of the heart in Chagas’ disease: Current status and new developments. Cardiovasc Res 2003;60:96-107.CrossRef
9.
Zurück zum Zitat Hiss FC, Lascala TF, Maciel BC, Marin-Neto JA, Simoes MV. Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas’ cardiomyopathy. JACC Cardiovasc Imaging 2009;2:164-72.CrossRef Hiss FC, Lascala TF, Maciel BC, Marin-Neto JA, Simoes MV. Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas’ cardiomyopathy. JACC Cardiovasc Imaging 2009;2:164-72.CrossRef
10.
Zurück zum Zitat Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, Ávila LF, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: A marker of disease severity. J Am Coll Cardiol 2005;46:1553-8.CrossRef Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, Ávila LF, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: A marker of disease severity. J Am Coll Cardiol 2005;46:1553-8.CrossRef
11.
Zurück zum Zitat Penfield JG, Reilly RF. What nephrologists need to know about gadolinium. Nat Clin Pract Nephrol 2007;3:654-68.CrossRef Penfield JG, Reilly RF. What nephrologists need to know about gadolinium. Nat Clin Pract Nephrol 2007;3:654-68.CrossRef
12.
Zurück zum Zitat Geraldes CFGC, Laurent S. Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging 2009;4:1-23.CrossRef Geraldes CFGC, Laurent S. Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging 2009;4:1-23.CrossRef
13.
Zurück zum Zitat Ibrahim T, Nekolla SG, Hörnke M, Bülow HP, Dirschinger J, Schömig A, et al. Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: Comparison with single-photon emission tomography using Tc99m-sestamibi. J Am Coll Cardiol 2005;45:544-52.CrossRef Ibrahim T, Nekolla SG, Hörnke M, Bülow HP, Dirschinger J, Schömig A, et al. Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: Comparison with single-photon emission tomography using Tc99m-sestamibi. J Am Coll Cardiol 2005;45:544-52.CrossRef
14.
Zurück zum Zitat Moon JCC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;43:2260-4.CrossRef Moon JCC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;43:2260-4.CrossRef
15.
Zurück zum Zitat Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8.CrossRef Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8.CrossRef
16.
Zurück zum Zitat McCrohon JA, Moon JCC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJS, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-9.CrossRef McCrohon JA, Moon JCC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJS, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-9.CrossRef
17.
Zurück zum Zitat Yuan Y. Step-sizes for the gradient method. AMS/IP Stud Adv Math 2008;42:785-96. Yuan Y. Step-sizes for the gradient method. AMS/IP Stud Adv Math 2008;42:785-96.
18.
19.
Zurück zum Zitat Hajnal JV, Hawkes D, Hill DLG. Medical image registration (biomedical engineering). Boca Raton: CRC Press; 2001. p. 392.CrossRef Hajnal JV, Hawkes D, Hill DLG. Medical image registration (biomedical engineering). Boca Raton: CRC Press; 2001. p. 392.CrossRef
20.
Zurück zum Zitat Snyman JA. Practical mathematical optimization. Cambridge: Springer; 2005. Snyman JA. Practical mathematical optimization. Cambridge: Springer; 2005.
21.
Zurück zum Zitat Zhu C, Byrd RH, Lu P, Nocedal J. Algorithm 778: L-BFGS-B: Fortran subroutines for large-scale bound-constrained optimization. ACM Trans Math Softw 1997;23:550-60.CrossRef Zhu C, Byrd RH, Lu P, Nocedal J. Algorithm 778: L-BFGS-B: Fortran subroutines for large-scale bound-constrained optimization. ACM Trans Math Softw 1997;23:550-60.CrossRef
22.
Zurück zum Zitat Schroeder W. The ITK Software Guide Second Edition Updated for ITK version 2. 4. FEBS Lett 2005;525:53-8. Schroeder W. The ITK Software Guide Second Edition Updated for ITK version 2. 4. FEBS Lett 2005;525:53-8.
23.
Zurück zum Zitat Schroeder W, Martin K, Lorensen B. The visualization toolkit: An object-oriented approach to 3D graphics, 4th ed. Kitware, editor. Upper Saddle River: Prentice Hall; 2006 Schroeder W, Martin K, Lorensen B. The visualization toolkit: An object-oriented approach to 3D graphics, 4th ed. Kitware, editor. Upper Saddle River: Prentice Hall; 2006
24.
Zurück zum Zitat Ranganath S. Contour extraction from cardiac MRI studies using snakes. Med Imaging IEEE Trans 1995;14:328-38.CrossRef Ranganath S. Contour extraction from cardiac MRI studies using snakes. Med Imaging IEEE Trans 1995;14:328-38.CrossRef
25.
Zurück zum Zitat Caselles V, Kimmel R, Sapiro G. Geodesic active contours. Int J Comput Vis 1997;10:1467-75. Caselles V, Kimmel R, Sapiro G. Geodesic active contours. Int J Comput Vis 1997;10:1467-75.
26.
Zurück zum Zitat Petitjean C, Dacher JN. A review of segmentation methods in short axis cardiac MR images. Med Image Anal 2011;15:169-84.CrossRef Petitjean C, Dacher JN. A review of segmentation methods in short axis cardiac MR images. Med Image Anal 2011;15:169-84.CrossRef
27.
Zurück zum Zitat Tavakoli V, Amini AA. A survey of shaped-based registration and segmentation techniques for cardiac images. Comput Vis Image Underst 2013;117:966-89.CrossRef Tavakoli V, Amini AA. A survey of shaped-based registration and segmentation techniques for cardiac images. Comput Vis Image Underst 2013;117:966-89.CrossRef
28.
Zurück zum Zitat Matsunari I, Schricke U, Bengel FM, Haase H, Barthel P, Schmidt G, et al. Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation 2000;101:2579-85.CrossRef Matsunari I, Schricke U, Bengel FM, Haase H, Barthel P, Schmidt G, et al. Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation 2000;101:2579-85.CrossRef
30.
Zurück zum Zitat Marin-Neto JA, Marzullo P, Marcassa C, Gallo L, Maciel BC, Bellina CR, et al. Myocardial perfusion abnormalities in chronic Chagas’ disease as detected by thallium-201 scintigraphy. Am J Cardiol 1992;69:780-4.CrossRef Marin-Neto JA, Marzullo P, Marcassa C, Gallo L, Maciel BC, Bellina CR, et al. Myocardial perfusion abnormalities in chronic Chagas’ disease as detected by thallium-201 scintigraphy. Am J Cardiol 1992;69:780-4.CrossRef
31.
Zurück zum Zitat Dhiman M, Coronado YA, Vallejo CK, Petersen JR, Ejilemele A, Nuñez S, et al. Innate immune responses and antioxidant/oxidant imbalance are major determinants of human Chagas disease. PLoS Negl Trop Dis. 2013;7:e2364.CrossRef Dhiman M, Coronado YA, Vallejo CK, Petersen JR, Ejilemele A, Nuñez S, et al. Innate immune responses and antioxidant/oxidant imbalance are major determinants of human Chagas disease. PLoS Negl Trop Dis. 2013;7:e2364.CrossRef
Metadaten
Titel
Relationship between microvascular changes, autonomic denervation, and myocardial fibrosis in Chagas cardiomyopathy: Evaluation by MRI and SPECT imaging
verfasst von
Gustavo Canavaci Barizon, MSc
Marcus Vinicius Simões, MD, PhD
André Schmidt, MD, PhD
Leonardo Pippa Gadioli, MD, PhD
Luiz Otávio Murta Junior, PhD
Publikationsdatum
25.04.2018
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 2/2020
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-018-1290-z

Weitere Artikel der Ausgabe 2/2020

Journal of Nuclear Cardiology 2/2020 Zur Ausgabe

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.